News and Trends 5 Mar 2018 Danish Biotech Starts Phase III Atopic Dermatitis Trial With Failed Asthma Treatment Danish biotech LEO Pharma started a Phase III trial in atopic dermatitis with an antibody that AstraZeneca dropped after failing two Phase III trials in asthma. LEO Pharma is taking… March 5, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
Best in Biotech 22 Dec 2021 The Biggest European Biotech News of 2021 …to be absorbed into the US firm Enbiotix after disappointing results from drug candidates for bacterial infections and cancer. Meanwhile, fresh waves of Covid-19 dog efforts to return to normality…. December 22, 2021 - 10 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 12 Oct 2022 Novavax COVID-19 vaccine data supports homologous and heterologous boosting …a type of antibody) levels increased significantly relative to pre-boost levels, rising above the level correlated with 95% vaccine efficacy in a recent USG study. Neutralizing antibodies against the prototype… October 12, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
Interview 17 Apr 2017 Meet One of the Most Successful German Biotech Leaders Ever …looked like a disaster in the first place, created the opportunity to develop a bispecific T cell-engaging antibody that was in-licensed from inventors at Munich’s LMU. This antibody ultimately became… April 17, 2017 - 6 minutesmins - By Philip Hemme Share WhatsApp Twitter Linkedin Email
In Depth 15 Aug 2025 How biotech is improving the life of your cat …from human or canine drugs isn’t a durable option. If you give a cat a human or dog-like antibody, the cat’s immune system may attack it. So, companies build the… August 15, 2025 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 30 Aug 2017 German Scientists Publish New Mechanism of Action Against Alzheimer’s …developing a therapeutic antibody with a unique mode of action against Alzheimer’s, PBD-C06. The company announced yesterday the publication in the Journal of Biological Chemistry of the detailed binding mechanism… August 30, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 13 Oct 2022 Merck contributing to Jacobio Pharma colorectal cancer clinical trial …treatment; combination therapy with SHP2 inhibitor, PD-1 monoclonal antibody and cetuximab. About Erbitux (cetuximab) Erbitux is an IgG1 monoclonal antibody targeting the epidermal growth factor receptor (EGFR). As a monoclonal… October 13, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 14 Jul 2022 GenScript ProBio enters strategic partnerships with two South Korean biotechs …DAAN Bio Therapeutics Based in Seoul, South Korea, DAAN Bio Therapeutics has developed an integrated immune-oncology drug research platform for the discovery of novel antibody and cell therapy drugs for… July 14, 2022 - 3 minutesmins - By Omnia Ibrahim Share WhatsApp Twitter Linkedin Email
News and Trends 30 Sep 2024 The race for a bird flu vaccine: milestones and breakthroughs …platform could be leveraged to rapidly provide a vaccine candidate targeting the specific pandemic influenza strain.” Pfizer’s phase 1 mRNA vaccine candidate encodes the hemagglutinin (HA) antigen of a pandemic… September 30, 2024 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 2 Jul 2025 Top biotech deals in June 2025 …was slashed earlier this year. Meanwhile, this is XOMA Royalty’s second purchase in a month after it snagged the monoclonal antibody mezagitamab from the Swedish company BioInvent for $20 million. … July 2, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 20 Jul 2022 BigHat Biosciences raises $75M to design safer, more effective antibodies A company developing safer, more effective antibody therapies for patients using machine learning and synthetic biology, today (July 20) announced it has raised $75 million in funding. BigHat Biosciences’ series… July 20, 2022 - 4 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 10 Apr 2020 Coronavirus Pandemic Bites into European Cancer Research …which specializes in cancer immunotherapy, has temporarily halted patient recruitment into phase I clinical trials for two of its cancer drug candidates, a bispecific antibody and a monoclonal antibody. On… April 10, 2020 - 4 minutesmins - By Anita Chakraverty Share WhatsApp Twitter Linkedin Email